ZBTB16-RARalpha variant of acute promyelocytic leukemia with tuberculosis: a case report and review of literature.
10.5045/kjh.2012.47.3.229
- Author:
Anshu PALTA
1
;
Pratibha DHIMAN
;
Sanjay D CRUZ
Author Information
1. Department of Pathology, Government Medical College and Hospital, Chandigarh, India. dhimandrpratibha@yahoo.com
- Publication Type:Case Report
- Keywords:
ZBTB16-RARalpha variant;
Tuberculosis;
Promyelocytes
- MeSH:
Anemia;
Bone Marrow;
Cytogenetic Analysis;
Diagnosis, Differential;
Granulocyte Precursor Cells;
HLA-DR Antigens;
Humans;
Leukemia, Myeloid, Acute;
Leukemia, Promyelocytic, Acute;
Lower Extremity;
Male;
Tretinoin;
Tuberculosis;
Tuberculosis, Pulmonary;
Young Adult
- From:Korean Journal of Hematology
2012;47(3):229-232
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 23-year-old male presented with pulmonary tuberculosis and swelling of both lower limbs. He was put on antitubercular treatment. Hemogram showed mild anemia and Pseudo Pelger-huet cells. The bone marrow (BM) examination showed 52% promyelocytes with regular round to oval nuclei, few granules and were positive for CD13 and CD33, and negative for HLA-DR. Cytogenetic analysis of the BM aspirate revealed an apparently balanced t(11;17)(q23;q21). Final diagnosis rendered was acute promyelocytic leukemia (APL) with t(11;17)(q23;q21); ZBTB16/RARA. APL is a distinct subtype of acute myeloid leukemia. The variant APL with t(11;17)(q23;q21) cases that are associated with the ZBTB16/RARA fusion gene have been reported as being resistant to all-trans-retinoic acid (ATRA). Therefore, differential diagnosis of variant APL with t(11;17)(q23;q12) from classical APL with t(15;17)(q22;q12); PML-RARA is very important. Here we have discussed the importance of distinct morphology of variant APL and also significance of rare presentation with tuberculosis.
